Resultados de la búsqueda 241-250 of 9617 for monoclonal antibody

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

2. Cirugía - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

3. Cirugía - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving acalabrutinib ...

5. Hematología - Ensayos clínicos - Mayo Clinic

   ... monoclonal antibody, and compare them with clinical outcomes. Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now. Rochester ...

6. Hematología - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

7. Hematología - Ensayos clínicos

   Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells ...

8. Cirugía - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

9. Hematología - Ensayos clínicos

   Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells ...

10. Hematología - Ensayos clínicos

    Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving acalabrutinib ...